evidencegaps
Reviews

Systematic reviews

Search a topic, title, author or review id. The Findings tab shows what the reviews found for the same words, grouped by question; the Studies tab shows the primary studies they include.

15 reviews, newest first

Pegylated liposomal doxorubicin for relapsed epithelial ovarian cancer

Newhouse, R, Nelissen, E, et al. · Cochrane Database of Systematic Reviews · 2023
Cochraneheadline outcomes only
21 findings

PEG‐asparaginase treatment regimens for acute lymphoblastic leukaemia in children: a network meta‐analysis

Lynggaard, LS, Rank, CU, et al. · Cochrane Database of Systematic Reviews · 2023
Cochraneheadline outcomes only
21 findings

Unconditional cash transfers for reducing poverty and vulnerabilities: effect on use of health services and health outcomes in low‐ and middle‐income countries

Pega, F, Pabayo, R, et al. · Cochrane Database of Systematic Reviews · 2022
Cochraneheadline outcomes only
21 findings

Certolizumab pegol for maintenance of medically induced remission in Crohn’s disease

Okabayashi, S, Yamazaki, H, et al. · Cochrane Database of Systematic Reviews · 2022
Cochraneheadline outcomes only
3 findings

Taxation of unprocessed sugar or sugar‐added foods for reducing their consumption and preventing obesity or other adverse health outcomes

Pfinder, M, Heise, TL, et al. · Cochrane Database of Systematic Reviews · 2020
Cochraneheadline outcomes only
11 findings

Taxation of the fat content of foods for reducing their consumption and preventing obesity or other adverse health outcomes

Lhachimi, SK, Pega, F, et al. · Cochrane Database of Systematic Reviews · 2020
Cochraneheadline outcomes only
6 findings

Pharmacological interventions for treating chronic prostatitis/chronic pelvic pain syndrome

Franco, JVA, Turk, T, et al. · Cochrane Database of Systematic Reviews · 2019
Cochraneheadline outcomes only
48 findings

Certolizumab pegol for induction of remission in Crohn's disease

Yamazaki, H, So, R, et al. · Cochrane Database of Systematic Reviews · 2019
Cochraneheadline outcomes only
3 findings

Certolizumab pegol (CDP870) for rheumatoid arthritis in adults

Ruiz Garcia, V, Burls, A, et al. · Cochrane Database of Systematic Reviews · 2017
Cochraneheadline outcomes only
7 findings

Unconditional cash transfers for assistance in humanitarian disasters: effect on use of health services and health outcomes in low‐ and middle‐income countries

Pega, F, Liu, SY, et al. · Cochrane Database of Systematic Reviews · 2015
Cochraneheadline outcomes only
14 findings

Peginterferon plus ribavirin versus interferon plus ribavirin for chronic hepatitis C

Hauser, G, Awad, T, et al. · Cochrane Database of Systematic Reviews · 2014
Cochraneheadline outcomes only
3 findings

Peginterferon alpha‐2a versus peginterferon alpha‐2b for chronic hepatitis C

Hauser, G, Awad, T, et al. · Cochrane Database of Systematic Reviews · 2014
Cochraneheadline outcomes only
7 findings

In‐work tax credits for families and their impact on health status in adults

Pega, F, Carter, K, et al. · Cochrane Database of Systematic Reviews · 2013
Cochraneheadline outcomes only
16 findings

Pegylated liposomal doxorubicin for first‐line treatment of epithelial ovarian cancer

Lawrie, TA, Rabbie, R, et al. · Cochrane Database of Systematic Reviews · 2013
Cochraneheadline outcomes only
6 findings

Extended peginterferon plus ribavirin treatment for 72 weeks versus standard peginterferon plus ribavirin treatment for 48 weeks in chronic hepatitis C genotype 1 infected slow‐responder adult patients

Katz, LH, Goldvaser, H, et al. · Cochrane Database of Systematic Reviews · 2012
Cochraneheadline outcomes only
7 findings